Sessioni Comunicazioni Orali
Stem cells in cardiovascular diseases
Giovedì 29 Ottobre 2015 / 14.00-15.45
| 375 | Beta-blocker treatment in heart failure patients correlates with successful isolation of resident cardiac progenitor cells and affects their phenotype through EMT modulation Pagano F., Cavaretta E., Siciliano C., Mangino G., Peruzzi M., Marullo A., Sciarretta S., Biondi Zoccai G., Chimenti I., Frati G. |
| 387 | Cardiac stem cells are indispensable for heart homeostasis and repair Torella D., Vicinanza C., Aquila I., Scalise M., Marino F., Mancuso T., Cianflone E., Mollace V., Indolfi C. |
| 491 | Impact of heart failure on cardiac stem cells Gianfranceschi G., Caragnano A., Mazzega E., Sponga S., Livi U., Aleksova A., Cesselli D., Beltrami AP. |
| 605 | Modeling congenital heart defects with pluripotent stem cells: insights from human embryonic stem cells with trisomy 21 Sartiani L., Bosman A., Letourneau A., Del Lungo M., Ronzoni F., Kuziakiv R., Tohonen V., Zucchelli M., Santoni F., Guipponi M., Dumevska B., Hovatta O., Antonarakis S., Jaconi M. |
| 611 | Clinical trials in cardiovascular cell therapy: where we are going Bassetti B., Spaltro G., Cavallotti L., Catto V., Carbucicchio C., Pompilio G. |
| 612 | Cellular basis of drug induced heart failure: role of stem cells Urbanek K., Quaini F., Cappetta D., Piegari E., Esposito G., Russo R., Frati C., Berrino L., De Angelis A., Rossi F. |
| 659 | Improving the therapeutic properties of mesenchymal stromal cells for ischemic heart disease Gnecchi M. |